HAVCR2 and hepatocellular carcinoma: For example, T cell immunoglobulin and mucin domain 3 (TIM-3) is a kind of immunomodulatory receptor which can bind with ligands on tumor cells in the microenvironment to inhibit antitumor immunity in a variety of cancers, including HCC.